deoxycytidine and Congenital Thrombotic Thrombocytopenic Purpura

deoxycytidine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (47.06)	29.6817
2010's	8 (47.06)	24.3611
2020's	1 (5.88)	2.80

Authors

Authors	Studies
Esposito, F; Font, C; Garcia de Herreros, M; Sauri, T	1
Bittar, PG; Nickolich, MS; Onwuemene, OA	1
Fujimura, Y; Himeno, A; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kumanogoh, A; Matsumoto, M; Nagatomo, I; Nishijima, Y; Otani, Y; Tachibana, I; Takahashi, R; Takeda, Y	1
Held-Warmkessel, J	1
Aster, RH; Bougie, DW; Curtis, BR; George, JN; Reese, JA; Terrell, DR; Vesely, SK	1
Cabezuelo, B; de la Vara Inesta, L; Illescas, ML; Jimeno García, L; López Rubio, ME; Lucas Guillén, E; Martinez Díaz, M; Mateo Bosch, E; Morales Albuja, ME; Rodado Martínez, R	1
Bitzer, M; Fend, F; Finkenwirth, P; Gregor, M; Horger, MS; Lauer, UM; Schick, D	1
Bliziotis, I; Makrilia, N; Saif, MW; Syrigos, K; Xyla, V	1
Arce-Lara, C; Bekaii-Saab, T; Cataland, S; Kraut, E; Ntukidem, N; Otterson, GA	1
Clark, WF; Robinson, A	1
Gourley, BL; Gupta, P; Mesa, H	1
Clark, JW; Henderson, JM; Humphreys, BD; Magee, CC; Marks, PW; Rennke, HG; Sharman, JP; Zhu, AX	1
Shah, PC; Shah-Khan, F; Zupancic, M	1
Thachil, J	1
De Smet, D; Jochmans, K; Neyns, B	1
Behne, MJ; Brüllke, N; Hauswirth, U; Menz, A; Moll, I; Müllerleile, U	1
Caca, K; Helmchen, U; Schmidt, A; Schwella, N; von Renteln, D	1

Reviews

2 review(s) available for deoxycytidine and Congenital Thrombotic Thrombocytopenic Purpura

Article	Year
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Irinotecan; Mitomycin; Prospective Studies; Purpura, Thrombotic Thrombocytopenic	2010
Gemcitabine-associated thrombotic thrombocytopenic purpura. The Lancet. Oncology, 2007, Volume: 8, Issue:7 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Purpura, Thrombotic Thrombocytopenic; Ribonucleotide Reductases	2007

Article

Year

Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.

Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Irinotecan; Mitomycin; Prospective Studies; Purpura, Thrombotic Thrombocytopenic

2010

Gemcitabine-associated thrombotic thrombocytopenic purpura.

The Lancet. Oncology, 2007, Volume: 8, Issue:7

Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Purpura, Thrombotic Thrombocytopenic; Ribonucleotide Reductases

2007

Other Studies

15 other study(ies) available for deoxycytidine and Congenital Thrombotic Thrombocytopenic Purpura

Article	Year
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Paclitaxel; Pancreatic Neoplasms; Purpura, Thrombotic Thrombocytopenic; Thrombotic Microangiopathies	2023
ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy. Journal of clinical apheresis, 2018, Volume: 33, Issue:3 Topics: ADAMTS13 Protein; Deoxycytidine; Diagnosis, Differential; Female; Gemcitabine; Humans; Middle Aged; Plasma Exchange; Practice Guidelines as Topic; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombotic Microangiopathies	2018
Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10 Topics: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Erlotinib Hydrochloride; Female; Gemcitabine; Glutamates; Guanine; Humans; Hypertension; Lung Neoplasms; Middle Aged; Oxonic Acid; Pemetrexed; Plasma; Purpura, Thrombotic Thrombocytopenic; Pyridines; Quinazolines; Recombinant Proteins; Solubility; Taxoids; Tegafur; Thrombomodulin	2013
Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Oncology nursing forum, 2014, Volume: 41, Issue:5 Topics: Adenocarcinoma; Antibodies, Monoclonal, Murine-Derived; Antihypertensive Agents; Antimetabolites, Antineoplastic; Blood Component Transfusion; Deoxycytidine; Disease Management; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension; Kidney Failure, Chronic; Nursing Assessment; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Rituximab	2014
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. American journal of hematology, 2015, Volume: 90, Issue:5 Topics: Ambulatory Care Facilities; Antibodies; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Oklahoma; Organoplatinum Compounds; Oxaliplatin; Pentostatin; Purpura, Thrombotic Thrombocytopenic; Quinine; Registries; Thrombotic Microangiopathies; Vancomycin; Wisconsin	2015
Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports . Clinical nephrology, 2017, Volume: 87 (2017), Issue:2 Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney Function Tests; Male; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Treatment Outcome	2017
[Thrombotic microangiopathy under an effective treatment with gemcitabine]. Zeitschrift fur Gastroenterologie, 2009, Volume: 47, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Large Cell; Deoxycytidine; Erythrocytes; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Liver Neoplasms; Male; Palliative Care; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome	2009
Thrombotic microangiopathy associated with gemcitabine: rare but real. Expert opinion on drug safety, 2009, Volume: 8, Issue:3 Topics: Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Purpura, Thrombotic Thrombocytopenic	2009
A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura). Journal of gastrointestinal cancer, 2010, Volume: 41, Issue:1 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Duodenal Neoplasms; Female; Gemcitabine; Humans; Middle Aged; Omentum; Pancreas; Peritoneal Neoplasms; Purpura, Thrombotic Thrombocytopenic	2010
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Blood Cell Count; Blood Platelets; Creatinine; Deoxycytidine; Gemcitabine; Hemoglobins; Hemolytic-Uremic Syndrome; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Rituximab	2010
Gemcitabine-associated thrombotic microangiopathy. Cancer, 2004, Jun-15, Volume: 100, Issue:12 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension; Incidence; Male; Microcirculation; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Vascular Diseases	2004
Causes of thrombotic thrombocytopenic purpura. The Lancet. Oncology, 2007, Volume: 8, Issue:9 Topics: Deoxycytidine; Endothelial Cells; Gemcitabine; Humans; Neoplasms; Purpura, Thrombotic Thrombocytopenic	2007
Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine. Annals of hematology, 2008, Volume: 87, Issue:6 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis	2008
[Acral necrosis in metastatic ovarian carcinoma. A single episode of Moschowitz syndrome during gemcitabine chemotherapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2008, Volume: 59, Issue:11 Topics: Deoxycytidine; Female; Fingers; Gemcitabine; Hand Dermatoses; Humans; Middle Aged; Necrosis; Ovarian Neoplasms; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome	2008
[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)]. Der Internist, 2008, Volume: 49, Issue:8 Topics: Adrenal Cortex Neoplasms; Adult; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Biopsy; Blindness; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Kidney; Male; Purpura, Thrombotic Thrombocytopenic	2008